Ultragenyx Pharmaceutical Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Ultragenyx Pharmaceutical Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Ultragenyx Pharmaceutical Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Ultragenyx Pharmaceutical Inc. is RARE:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Ultragenyx Pharmaceutical Inc. has its primary listing on NASDAQ. You can trade Ultragenyx Pharmaceutical Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Ultragenyx Pharmaceutical Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Ultragenyx Pharmaceutical Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Ultragenyx Pharmaceutical Inc..